4th Quarter - Report
IKARIA for IKARIA
Firm
Client
Income
—
Expenses
$200,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR2227 Medical Gas Safety Act HR 971 Critical Care Assessment and Improvement Act of 2011 FDA Legislation including Prescription Drug and Medical Device User Fees
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN SPEAR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.